We are live on ! Find out more
CH

CVI Holdings Portfolio holdings

AUM $116M
1-Year Est. Return 5.68%
This Fund
S&P 500
This Quarter Est. Return
-22.52%
1 Year Est. Return
+5.68%
3 Year Est. Return
+25.77%
5 Year Est. Return
+327.29%
10 Year Est. Return
AUM
$44.9M
AUM Growth
-$15.6M
Cap. Flow
-$20.7M
Cap. Flow %
-46%
Top 10 Hldgs %
92.09%
Holding
59
New
11
Increased
2
Reduced
13
Closed
16

Sector Composition

Rank Sector Weight
1 Healthcare 41.92%
2 Communication Services 7.57%
3 Materials 1.49%
4 Utilities 0.38%
5 Technology 0.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BVXVW
26
DELISTED
BiondVax Pharmaceuticals Ltd.
BVXVW
$31K 0.07%
72,800
FPAYW
27
DELISTED
FlexShopper, Inc. Warrants
FPAYW
$14K 0.03%
50,000
IMRNW
28
DELISTED
Immuron Limited Warrants
IMRNW
$13K 0.03%
10,941
CREXW
29
DELISTED
Creative Realities, Inc. Warrant
CREXW
$6K 0.01%
+15,000
New +$7.21K
BNTCW
30
DELISTED
Benitec Biopharma Limited
BNTCW
$6K 0.01%
50,000
ONTXW
31
DELISTED
Onconova Therapeutics, Inc. Warrants
ONTXW
$5K 0.01%
132,227
-37,773
-22% -$3.21K
AMRHW
32
DELISTED
Ameri Holdings, Inc. Warrant
AMRHW
$5K 0.01%
99,500
-26,003
-21% -$1.95K
SNGXW
33
DELISTED
Soligenix, Inc. Warrant
SNGXW
$4K 0.01%
16,599
-44,401
-73% -$11K
APOPW
34
DELISTED
Cellect Biotechnology Ltd. Warrants to Purchase ADRs
APOPW
$4K 0.01%
12,498
-72
-0.6% -$92
CYTXZ
35
DELISTED
Cytori Therapeutics Inc Series S Warrant
CYTXZ
$2K ﹤0.01%
259,200
MYNDW
36
DELISTED
MYnd Analytics, Inc. Warrant
MYNDW
$1K ﹤0.01%
13,700
ALDX icon
37
Aldeyra Therapeutics
ALDX
$97.1M
-200,000
Closed -$2.76M
ALT icon
38
Altimmune
ALT
$568M
-92,768
Closed -$408K
BNBX
39
DELISTED
BNB PLUS CORP
BNBX
0
-$412K
ARGX icon
40
argenx
ARGX
$55.2B
-11,527
Closed -$874K
ATXS
41
DELISTED
Astria Therapeutics
ATXS
-12,172
Closed -$584K
DOO
42
Bombardier Recreational Products
DOO
$4.48B
-133,226
Closed -$6.25M
IRIX icon
43
IRIDEX
IRIX
$15M
-25,799
Closed -$164K
MRKR icon
44
Marker Therapeutics
MRKR
$18.5M
-25,000
Closed -$2.26M
RCON icon
45
Recon Technology
RCON
$32.2M
-396
Closed -$44K
RDHL
46
Redhill Biopharma
RDHL
$4.44M
-22
Closed -$198K
URG
47
Ur-Energy
URG
$469M
-732,548
Closed -$586K
GTHX
48
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
-84,249
Closed -$4.41M
PLXP
49
DELISTED
PLx Pharma Inc. Common Stock
PLXP
-13,878
Closed -$56K
OPNT
50
DELISTED
Opiant Pharmaceuticals, Inc. Common Stock
OPNT
-13,715
Closed -$245K

Similar funds

CVI Holdings's Q4 2018 Portfolio in Review

As of Q4 2018, CVI Holdings held 59 positions worth $44.9M, down 26% from $60.5M the previous quarter. Its ten largest holdings account for 92% of the portfolio.

CVI Holdings withdrew a net $20.7M in Q4 2018, closing 16 positions and reducing 13 holdings. Its most notable exit was Bombardier Recreational Products, an estimated $6.25M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 42% of assets, up from 33% a quarter earlier, followed by Communication Services and Materials.

Against the trend, CVI Holdings opened a new position in MannKind Corp worth $11.4M.

  • CVI Holdings's largest Q4 2018 buy was MannKind Corp: 10,716,080 shares worth $11.4M.
  • CVI Holdings added most to Eros Media World PLC in Q4 2018, an estimated $1.63M increase.
  • CVI Holdings's biggest Q4 2018 reduction was Advaxis Inc, cutting an estimated $634K.
  • CVI Holdings fully exited Bombardier Recreational Products in Q4 2018, selling an estimated $6.25M.
  • CVI Holdings's ten largest holdings make up 92% of its $44.9M portfolio in Q4 2018.
  • CVI Holdings opened 11 new positions and closed 16 in Q4 2018.
  • CVI Holdings's portfolio value fell 26% quarter-over-quarter to $44.9M.

Based on CVI Holdings's 13F filing for Q4 2018, filed 14 Feb 2019.